Oncology treatment outcome in human immunodeficiency virus-positive cancer cervix patients: Where we are and what we achieved?

Oncology treatment outcome in human immunodeficiency virus-positive cancer cervix patients: Where we are and what we achieved?

Objective: To find out the epidemiological factors and oncology treatment outcome in human immunodeficiency virus-positive cancer cervix patients (HPCCP). Materials and Methods: After institutional ethics committee approval, hospital case records of HPCCP registered at the radiation oncology departm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cancer research and therapeutics 2022-10, Vol.18 (6), p.1537-1540
Hauptverfasser: Waghmare, Chaitali, Bhanu, Arya, Dwivedi, Shreya, Pawar, Hemant, Ravichandran, Meenakshi, Jain, Vandana
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
Care and treatment
Cervical cancer
Cervix
Development and progression
Evaluation
HIV infection
Immune system
Oncology
Oncology, Experimental
Physiological aspects
Prognosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: To find out the epidemiological factors and oncology treatment outcome in human immunodeficiency virus-positive cancer cervix patients (HPCCP). Materials and Methods: After institutional ethics committee approval, hospital case records of HPCCP registered at the radiation oncology department from January 2011 to December 2018 were retrospectively studied. Results: The case records of 22 eligible HPCCP were studied. Median age at presentation was 42.5 years. 90.90% of the patients were below 55 years of age. The duration of symptom was
ISSN:0973-1482
1998-4138
DOI:10.4103/jcrt.JCRT_230_20